SNORD112: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: SNORD112

NCBI ID: G692215

SNORD112

Other Name(s): 14q(0) | Small nucleolar RNA, C/D box 112 | small nucleolar RNA, C/D box 112

SNORD112: A Potential Drug Target Or Biomarker for Various Diseases

SNORD112 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

The gene, located on chromosome 14q, encodes for a protein known as SNORD112, which is a member of the resource-sharing transfer RNA family (SNORD) family. This protein is involved in the delivery of nutrients and oxygen to cells throughout the body, and is a potential drug target in diseases where the delivery of essential nutrients is impaired.

Studies have suggested that SNORD112 may be involved in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, studies have found that SNORD112 is expressed in various types of cancer, and that its expression is associated with the poor prognosis of these diseases. Additionally, there is evidence to suggest that SNORD112 may be involved in the development of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, as well as autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In addition to its potential involvement in disease, SNORD112 has also been identified as a potential drug target. Researchers have found that SNORD112 is expressed in various types of cancer cells, and that inhibiting its expression may be an effective way to treat these diseases. Additionally , studies have suggested that SNORD112 may be involved in the development of neurodegenerative disorders, and that targeting this protein may be a promising approach to treating these conditions.

Overall, SNORD112 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Small Nucleolar RNA, C/D Box 112

The "SNORD112 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD112 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets